Lupin Arm Licenses Yuvezzi Marketing Rights From Visus

Lupin is a large medicine company.

Its subsidiary, VISUfarma, made a deal with Visus Therapeutics.

The deal is about a product called Yuvezzi.

Yuvezzi is an eye medicine for adults who cannot see things clearly up close.

VISUfarma will handle approvals, marketing and sales in certain countries.

The agreement gives VISUfarma exclusive rights in those markets.

Visus Therapeutics belongs entirely to Tenpoint Therapeutics Holding.

The announcement was made on Thursday in New Delhi.